Genomic analysis of different clonal evolution in a twin pair with t(12;21) positive acute lymphoblastic leukemia sharing the same prenatal clone
The cryptic translocation t(12;21), with the TEL-AML1 fusion gene, accounts for approximately 25% of childhood B-cell precursor acute lymphoblastic leukemia (ALL) cases. Several studies on monozygotic twins with concordant TEL-AML1-positive ALL have shown that these patients shared common, acquired clonal rearrangements that originated in one twin in utero and diffused to the other twin by a sort of intraplacental metastasis. 1, 2 A t(12;21) positive pair of twins was previously reported by Teuffel et al. 3 in this journal. In view of their analyses of T-cell receptor (TcR) and immunoglobulin (Ig) gene rearrangements, they concluded that the TEL-AML1 fusion gene occurred before somatic recombination and that separate pre-leukemic clones then evolved independently before birth. We herewith report a female pair of monozygotic twins, aged 3.0 years at concordant diagnosis of ALL, with only 13 days difference in latency. We analyzed the Ig/TcR rearrangements as clonotypic markers to backtrack the common pre-natal pre-leukemic cell shared by the twins. All markers present in both twins at diagnosis must have belonged to the pre-leukemic clone in utero. However, the Ig/TcR rearrangements in our twins suggest a different natural history, with the same Ig/TcR rearrangements being present at diagnosis in both twins, proving that the translocation occurred in a more mature precursor cell which was partially already rearranged, and was then followed by further clonal evolution.
Twin 1 (T1) and 2 (T2) displayed pre-B and common ALL (cALL) immunophenotypes, respectively. The TEL-AML1 fusion gene was assessed at diagnosis by reverse transcription-PCR. Unfortunately, due to lack of valuable metaphases, no cytogenetic analysis was performed to assess the presence of additional structural cytogenetic abnormalities. Neither Guthrie cards were available for further studies at birth. Diagnostic DNA Letters to the Editor of both twins was screened for the presence of clonal Ig/TcR rearrangements. Monoclonal rearrangements were sequenced and specific primers were designed to the junctional region. The primers with optimal sensitivity and specificity (as assessed against DNA of pooled mononuclear cells (MNCs) of five healthy donors) were used to quantify the minimal residual disease by real-time quantitative-PCR (RQ-PCR) on three followup time points (day þ 15, day þ 33 and day þ 78), as part of the AIEOP-LAL 2000 protocol. T1 revealed monoclonality for VKIKde, VKII-Kde, IRSS-Kde and Vg5-Jg1.3; the Ig rearrangement VH3-JH4 was oligoclonal. T2 had VKI-Kde, VKII-Kde and VH2-JH4 monoclonal gene rearrangements and a VH3-JH4 biallelic rearrangement ( Table 1 ). The sequence of the clone-specific junctional region of VKII-Kde was identical in both twins, demonstrating a common, pre-natal origin of the pre-leukemic clone in one twin in utero and its 'metastatic' diffusion into the other twin during pregnancy. Since both monozygotic twins had dichorionic placentas, this was probably achieved by diffusion through the mothers' blood. 1, 2 Moreover, the Kde junctional sequence of the VKI-Kde rearrangement was identical in T1 and T2, but two different VKI alleles were found (Table 1) , IGKV1-8 in T1 and IGKV1-17 in T2, suggesting a V-replacement process; 4 According to the relative position of the VKI alleles on the gene locus (http://imgt.cines.fr:8104/textes/IMGTrepertoire/), we can conclude that IGKV1-17 rearrangement in T2 preceded IGKV1-8 in T1.
To identify and quantify shared markers, besides VKII-Kde, belonging to the pre-natal, pre-leukemic clone, the diagnostic DNA of one twin was amplified by RQ-PCR, using specific primers of rearrangements detected in the other twin (indicated as 'cross-test'). The clone-specific markers of T1 did not amplify diagnostic DNA of T2. In contrast, three out of the four T2 markers were present at the diagnosis of T1: VKII, as expected, VH2-JH4 and one of the two alleles of VH3-JH4. All the T2 markers showed a lower load at diagnosis of T1 (4.4 Â 10 À3 , 3.2 Â 10 À4 and 5.0 Â 10
À5
, respectively), as quantified by RQ-PCR. The highest result was obtained for the shared VKII-Kde rearrangement, as expected (data not shown). The VH3-JH4 rearrangement revealed oligoclonality for T1, but none of the sequences cloned were identical to the T2 one. The presence of these three rearrangements in both twins at diagnosis can only be explained by a common clonal origin in utero.
Unfortunately, all the efforts to clone the TEL-AML1 genomic breakpoint to formally demonstrate this hypothesis were not successful. Specific additional markers were present at diagnosis in both twins: Vg5 and IRSS in T1 and a second VH3-JH4 in T2. Thus, these further Ig/TcR rearrangements may represent the independent and postnatal evolution of the leukemic clone; however, we cannot exclude the presence of additional minor clones that may escape the sensitivity reached by this assay. Furthermore, the fact that all the T2-sensitive markers have been detected in T1 can be explained by a more prolonged evolution of the T1 clone, which is also characterized by a more mature immunophenotype (pre-B versus cALL).
The latency occurring between the first hit (in utero) and the clinical manifestation supports the 'at least two-steps' (pre-and postnatal) etiological model for childhood ALL, where fetal initiation by TEL-AML1 fusion gene is insufficient for clinically overt leukemia, 2 as demonstrated by its presence in cord blood samples of healthy individuals. 5 Some additional postnatal genetic events must be necessary such as deletion of the second TEL allele, which represents the most frequent known aberration in t(12;21)-positive leukemia, being found in about 70% cases. 6 Since we have shown a common pre-natal t(12;21) malignant clone in our twin pair, we next aimed to search for secondary cryptic genetic aberrancies, which may explain the separate evolution of the shared pre-leukemic clone and therefore we performed genomic analysis of loss of heterozygosity (LOH) and gene copy-number variation by single-nucleotide polymorphism (SNP) arrays on the twin pair. LOH, either as a result of gene deletion or deriving from somatic recombination, has been recently pointed out as a frequent event in childhood ALL and in acute myeloid leukemia (AML). 7, 8 Genomic DNA from diagnosis and remission bone marrow (BM) samples of the twin pair was analyzed both with the GeneChip Human Mapping 10K Array Xba 142 2.0 and with the 100K Mapping Array (Affymetrix Inc., Santa Clara, CA, USA). Moreover, the genomic peripheral blood (PB) DNA of the parents was analyzed with the GeneChip Human Mapping 50K HindIII Array. Briefly, 250 ng (50 ng ml À1 ) of genomic DNA was processed following the GeneChip mapping assay protocol (Affymetrix Inc.). Washing and staining of GeneChip Mapping probe arrays were performed automatically in Affymetrix 450/250 Table 1 Analysis of Ig/TcR gene rearrangements found at diagnosis in both twins The Kde junctional sequence of the VKI-Kde rearrangement was identical in T1 and T2, but two different VKI alleles were found.
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Fluidics Station. The GeneChip Scanner 3000 was used to scan the arrays. SNP genotype and DNA copy number were inferred by SNP calls and signal intensity data, respectively, as acquired by the GTYPE/CNAT software (Affymetrix). Copy-number analysis was performed by the CNAG software (Genome Laboratory, Tokyo University, Tokyo, Japan). A large hemizygous deletion involving the short arm of chromosome 12 across the p12.2-p13 region from the telomere to 20.081 Mb was observed only in T2 (Figure 1a) . The deletion of the second, non-translocated TEL allele was confirmed by fluorescent in situ hybridization (FISH) analysis with the LSI TEL/ AML1 ES Dual Color Translocation Probe Set (Vysis, Downers Grove, IL, USA) (Figure 1b) . In addition, FISH analysis showed for T2 the presence of a smaller (6.9%) TEL-AML1-positive population retaining the second TEL allele, which escaped the sensitivity of SNP arrays. T1 did not show any 12p deletion by SNP array analysis, nor by FISH (data not shown). The residual TEL allele deletion was also confirmed by microsatellite analyses using markers TEL/KIPca1 and D12S98, which showed that it encompassed exons 1A to 3. No LOH was detected in T1 with the same markers used (data not shown). Thus, deletion of the second TEL allele might represent the additional hit responsible for the clinical emergence of ALL in T2, as it has been previously proposed. 6 In contrast, other genetic events, other than TEL deletion, must account for the second hit in T1. Although we cannot exclude a submicroscopical TEL deletion or mutation of the second TEL allele, unfortunately, there was insufficient material from T1 to perform sequencing of the TEL gene to rule out the presence of gene mutations.
Unexpectedly, SNP arrays revealed a large region of homozygosity not associated with copy-number change on chromosome 2 (1144 Mb on 2q13 to 1249 Mb on 2q14.3), both in the diagnosis and the remission samples of the twin pair (Figure 1c) . The copy number invariance was confirmed by FISH analysis with bacterial artificial chromosome (BAC)-derived probe RP11-416H1 mapping to the selected region (Figure 1d ). The genotyped SNP calls showed a homozygous stretch compatible with the presence of a putative germline segmental uniparental disomy. To assess the parental origin of the uniparental disomy fragment, microsatellite mapping of the chromosomal region involved in the LOH was performed, comparing twins and parental DNA (Figure 1e ). One single informative marker was found in this region (D12S437) and it indicated the presence of heterozygosity and biparental inheritance of the sequence tagged site (STS) alleles. To explain this apparent incongruence with the homozygosity and uniparental inheritance revealed by SNP arrays, we performed the 50K Mapping SNP Array on the DNA of twin's parents. This analysis showed the presence of heterozygous SNP calls on chromosome 2q13-q14.3 from both parents and the inheritance by the twins of a homozygous SNP genotype resulting from the fortuitous combination of both biparental alleles (Figure 1f ). This could also be related to the ethnic origin of this family (from Sardinia Island, Italy), which might explain the existence of more frequent homozygous SNP haplotypes because of far consanguinity. These specific findings also suggest that genomewide SNP genotyping, despite the high resolution offered, may be affected by the limit of having only two allelic (A/B) SNP variants, which in some cases needs to be confirmed with a more informative and multi-allelic markers such as microsatellites. One of the genes included in the 13 Mb LOH region on chromosome 2q13 is represented by TSN, coding for the translin protein (Online Mendelian Inheritance in Man (OMIM) no. 600575 for review). This protein was identified because of its binding to signal-like sequences both at the breakpoint junction of 8q24 and 1p32 in t(8;14)-and t(1;14)-positive ALLs, respectively, and to a target sequence within the breakpoint region of the BCL2 in follicular lymphomas with t(14;18). These binding properties at recombination hotspots may play a crucial role in chromosomal translocations in lymphoid neoplasms. Thus, a predisposing role for 2q13 LOH might be assumed; however, large studies are needed to assess this possibility.
In view of the overall analysis of the data reported here, we hypothesize the formation of t(12;21) translocation in a preleukemic CD10 þ , CD19 þ , cIgmÀ cell, already rearranged for VH3-JH4, VH2-JH4 and VKII-Kde.
Although the TEL/AML breakpoint cloning would have allowed a better understanding of the succession of events in this twin pair, the data produced and presented here, together with a review of the literature 1,9,10 can allow to depict a likely description of the events. More specifically, in this paper, we provided evidence that some Ig/TcR rearrangements present at leukemia diagnosis of one twin were present at a low level in the other twin, indicating that these rearrangements were already initiated before the separation of twins. We think that this situation someway simulates and recapitulates the relationship between the diagnostic and the relapse clones in singleton patients. Like in those cases, 9, 10 here, if the Ig/TcR rearrangement process begins after the first cell division of the TEL/AML1-positive cell was concluded, we would have found completely unrelated TEL/AML1-positive Ig/TcR subclones. On the other extreme, if the Ig/TcR rearrangement process occurred and finished before the TEL/AML1 fusion, then all TEL/AML1-positive cells would have had the same Ig/TCR pattern, while it is not the case. As an alternative and more likely situation, Ig/TcR rearrangement process was still ongoing when the translocation occurred. This can explain why these twins had some Ig/TcR rearrangements maintained, although at different levels, and other changed during the evolution process. This proposal fits best with the data from the analysis of the Ig/TcR rearrangements in the Guthrie cards and in the studies comparing TEL/AML1-positive clones at diagnosis and relapse. Overall, this model differs from the one hypothesized by Teuffel et al., 3 and may be explained by (i) the natural history and evolution of the pre-leukemic t(12;21) cell being heterogeneous in different patients or (ii) by the qualitative PCR used in the Teuffel paper, which may not be sufficiently sensitive and/or accurate to detect minor clonal populations. Further divergent clonal evolution then occurred in the twin pair. In T1, the preleukemic cell presented a more prolonged evolution until diagnosis, without any sub-microscopical abnormalities and with a more mature phenotype than T1, which was cIgm þ at diagnosis, and had additional IRSS-Kde and Vg5-Jg1.3 Ig gene rearrangements. T2 presented at diagnosis with a leukemic clone characterized by an earlier differentiation arrest than T1; one VH3-JH4 allele of Ig gene rearrangement and the deletion of non-translocated TEL allele represent markers of separate clonal evolution from T1. In conclusion, we did not find additional common sub-microscopical genetic events responsible for disease progression from the pre-leukemic to the overt leukemic stage. Although the TEL gene deletion seems to represent the sole additional change for T2, the almost contemporary onset of the disease in these patients and the presumed identical environmental risk exposure, does not exclude the presence of common secondary undetected cryptic changes, such as gene mutations.
